Nủria Malats - Epidemiology

Author Information

Nuria Malats is a prominent researcher affiliated with the Genetic and Molecular Epidemiology Group at the Spanish National Cancer Research Centre (CNIO) and CIBERONC in Madrid, Spain. Her extensive work in the field of cancer epidemiology, particularly focusing on pancreatic and bladder cancer, has been widely recognized and cited in the scientific community.

Research Contributions

Nuria Malats has made significant contributions to cancer research, particularly in the identification of biomarkers and genetic factors associated with cancer risk and prognosis. Her recent work includes the identification of microbial signatures predicting pancreatic cancer, the evaluation of the safety and efficacy of combined cancer therapies, and the exploration of somatic mutation profiles in liquid biopsies. Her research has also delved into the associations between genetic traits and cancer risks, as well as the impact of lifestyle factors such as smoking on cancer susceptibility.

Aliases

Nuria Malats is also known by several aliases including Nuría Malats, N Malats, N. Malats, and Núria Malats, among others.

Publication and Citation Metrics

Metric	Value
Total Citation Count	20256
h-index	79
Total Number of Papers	451

Publications:

Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study.

DOI: 10.1053/j.gastro.2022.03.054

Year: 2022

Phase I-II study to evaluate safety and efficacy of niraparib plus cabozantinib in patients with advanced urothelial/kidney cancer (NICARAGUA trial): Preliminary data of phase I study.

DOI: 10.1200/jco.2022.40.6_suppl.490

Year: 2022

A faecal microbiota signature with high specificity for pancreatic cancer

DOI: 10.1136/gutjnl-2021-324755

Year: 2022

Oral and fecal microbiome into the prediction of pancreatic cancer risk

DOI: 10.1016/j.pan.2022.02.019

Year: 2022

Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma

DOI: 10.1002/ijc.33464

Year: 2021

Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals KRAS Negativity and a Longer Overall Survival

DOI: 10.3390/cancers13071612

Year: 2021

Abstract 826: Large-scale genome-wide association study identifies multiple novel germline susceptibility variants associated with bladder cancer risk

DOI: 10.1158/1538-7445.AM2021-826

Year: 2021

Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma.

DOI: 10.1093/carcin/bgab057

Year: 2021

Tumor-Infiltrating B- and T-Cell Repertoire in Pancreatic Cancer Associated With Host and Tumor Features

DOI: 10.3389/fimmu.2021.730746

Year: 2021

Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3

DOI: 10.1158/0008-5472.CAN-20-3267

Year: 2021

How Can Epidemiologists Ensure GDPR Compliance?

How are Epidemiologic Data Utilized?

What is Satisfaction in Epidemiology?

What is AIDS and Why is Awareness Important?

Why Use a Factorial RCT?

What resources does Johns Hopkins provide for Epidemiology research?

What Does "Short Term" Mean in Epidemiology?

How Do Manufacturing Processes Impact Public Health?

How is Environmental Engineering Related to Epidemiology?

Why is Limited Healthcare Capacity a Problem?

Partnered Content Networks

Relevant Topics